Status:
COMPLETED
ICIS in Burn Patients Compared to Other Inflammatory Markers
Lead Sponsor:
Charles University, Czech Republic
Conditions:
Infection, Bacterial
Burns
Eligibility:
All Genders
6-100 years
Brief Summary
The current markers of inflammation that govern antibiotic treatment have their significant limitations, especially in patients with burns. According to previously published data, the newly proposed m...
Detailed Description
Improving the use of antibiotics is an important patient and public health issue. The misuse of antibiotics has contributed to the growing problem of antibiotic resistance, which has become one of the...
Eligibility Criteria
Inclusion
- All patients hospitalized on Prague Burn Centre, Czech Republic, for more than 3 days.
Exclusion
- Refusal to sign informed consent or withdrawal of already signed consent;
- Patient in palliative care.
Key Trial Info
Start Date :
April 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 31 2024
Estimated Enrollment :
97 Patients enrolled
Trial Details
Trial ID
NCT04894500
Start Date
April 1 2021
End Date
October 31 2024
Last Update
January 7 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Kralovske Vinohrady
Prague, Czechia, 10034